Across TCGA pan-cancer cohorts, PIP5K1A mass-spec protein differs between tumor and matched normal tissue in 4 of 18 cancer types tested, making tumor–normal expression one of PIP5K1A’s most consistent transcriptional readouts.
The strongest signal is observed in lung adenocarcinoma (LUAD), where PIP5K1A mass-spec protein is repressed in tumor relative to normal tissue. In most cancer types PIP5K1A is over-expressed in tumor, although a few such as LUAD and CCRCC show the opposite, repressed pattern.
LUAD, CCRCC, and LSCC are the cancer types where PIP5K1A tumor–normal differential expression is most reproducible.